Veeva Systems Inc. (VEEV)
Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next
Equity markets have been seesawing for the past two weeks. Stocks fell hard after President Donald Trump announced his tariff plans, then bounced back big once he said he would pause expanded tariffs on imported goods from most countries for 90 days.
Here is What to Know Beyond Why Veeva Systems Inc. (VEEV) is a Trending Stock
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note
Veeva Systems (VEEV) closed the most recent trading day at $222.72, moving -0.42% from the previous trading session.
Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last?
Veeva (VEEV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Why Is Veeva (VEEV) Down 6.2% Since Last Earnings Report?
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock?
VEEV Stock Slips Despite New Research Site Clinical Trial System
Veeva introduces a Research Site Clinical Trial Management System to streamline trial operations, enhance collaboration, and accelerate clinical research efficiency.
Wall Street Analysts Think Veeva (VEEV) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Veeva Systems: Staying Buy Rated As VEEV Is Executing Well
I reaffirm my buy rating on Veeva Systems due to strong 4Q25 results, driven by R&D growth and positive Vault CRM adoption traction. VEEV's revenue grew 14% y/y to $721 million, beating expectations, with significant margin improvements and a strong balance sheet. Vault CRM added 20 new customers, with multiple top 20 pharma commitments expected in 2025, signaling positive transition progress.
Veeva (VEEV) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
